Quoin Pharmaceuticals Ltd.
QNRX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001671502
In the last 90 days, Quoin Pharmaceuticals Ltd. insiders filed 4 open-market purchases and 0 sales; 19 institutions reported holding it in 13F filings for Q2 2026, worth $6.29M in total; no superinvestor holds it.
13F holders, Q4 2025
Institutional positions in Quoin Pharmaceuticals Ltd. as of Dec 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 18
- +14 vs. Q3 2025
- Shares held
- 842.8K
- +841.3K (+56,427.6%) vs. Q3 2025
- Total value
- $12.2M
- +$12.2M (+113,393.7%) vs. Q3 2025
- New holders
- 14
- 4 more added
- Sold out
- 0
- 0 more reduced
Compare with Q3 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting QNRX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 19 | $6.29M |
| Q1 2026 | 21 | $7.82M |
| Q4 2025 | 18 | $12.2M |
| Q3 2025 | 4 | $10.7K |
| Q2 2025 | 6 | $23.4K |
| Q1 2025 | 10 | $90.2K |
| Q4 2024 | 14 | $1.01M |
| Q3 2024 | 7 | $82.2K |
| Q2 2024 | 10 | $127.7K |
| Q1 2024 | 8 | $183.2K |
| Q4 2023 | 3 | $105.6K |
| Q3 2023 | 3 | $7.21K |
| Q2 2023 | 2 | $24.0K |
| Q1 2023 | 4 | $81.1K |
| Q4 2022 | 4 | $52.0K |
| Q3 2022 | 7 | $272.0K |
| Q2 2022 | 8 | $321.0K |
| Q1 2022 | 6 | $419.0K |
| Q4 2021 | 7 | $383.0K |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q4 2025
Shares, value and share of portfolio for each institution holding Quoin Pharmaceuticals Ltd.; share changes are against Q3 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Ikarian Capital, LLC | 211,538 | $3.05M | 0.40% | +211,538 | New |
| Woodline Partners LP | 79,582 | $1.15M | 0.00% | +79,582 | New |
| Stonepine Capital Management, LLC | 78,189 | $1.13M | 0.89% | +78,189 | New |
| Standard Life Aberdeen plc | 75,000 | $1.08M | 0.00% | +75,000 | New |
| Millennium Management LLC | 74,817 | $1.08M | 0.00% | +74,817 | New |
| SummitTX Capital, L.P. | 64,795 | $935.0K | 0.03% | +64,795 | New |
| Boothbay Fund Management, LLC | 59,838 | $863.5K | 0.02% | +59,838 | New |
| ADAR1 Capital Management, LLC | 58,230 | $840.3K | 0.06% | +58,230 | New |
| AIGH Capital Management LLC | 49,323 | $711.7K | 0.21% | +49,323 | New |
| Resolute Capital Asset Partners LLC | 30,000 | $432.9K | 0.21% | +30,000 | New |
| Soleus Capital Management, L.P. | 25,000 | $360.8K | 0.02% | +25,000 | New |
| Simplify Asset Management Inc. | 17,448 | $251.8K | 0.00% | +17,448 | New |
| Centiva Capital, LP | 12,053 | $173.9K | 0.01% | +12,053 | New |
| Morgan Stanley | 3,000 | $43.3K | 0.00% | +3,000 | New |
| GAMMA Investing LLC | 2,084 | $30.1K | 0.00% | +1,806+649.6% | Added |
| Rhumbline Advisers | 1,666 | $24.0K | 0.00% | +456+37.7% | Added |
| SBI Securities Co., Ltd. | 247 | $3.56K | 0.00% | +245+12,250.0% | Added |
| UBS Group AG | 17 | $245 | 0.00% | +16+1,600.0% | Added |